Description

2(1H)-Quinolinone, 3,4-Dihydro-6-(3-(4-(2-Methoxyphenyl)-1-Piperidinyl )Propyl)-, Ethanedioate(1:1) is a high-purity, complex organic salt of significant interest in advanced pharmaceutical research and development. This compound matters as a key synthetic intermediate or potential active pharmaceutical ingredient (API) for targeting specific neurological or cardiovascular pathways. It is primarily needed by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers engaged in the synthesis of novel therapeutic agents.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the multi-step synthesis of novel drug candidates, particularly in central nervous system (CNS) or cardiovascular research.
• Biochemical Research: Used as a reference standard or tool compound in pharmacological studies to investigate receptor binding affinity and enzyme inhibition.
• Preclinical Development: Employed in the formulation and testing stages for new chemical entities (NCEs) prior to clinical trials.
• Process Chemistry: Utilized in route scouting and optimization for the scalable production of target molecules within GMP environments.
• Academic Research: Facilitates organic and medicinal chemistry studies in university and institutional laboratories focused on heterocyclic compound synthesis.

Basic Information

Product Name	2(1H)-Quinolinone, 3,4-Dihydro-6-(3-(4-(2-Methoxyphenyl)-1-Piperidinyl )Propyl)-, Ethanedioate(1:1)
CAS No.	80834-78-2
Molecular Formula	C26H30N2O5
Molecular Weight	450.53 g/mol
Synonyms	6-[3-[4-(2-Methoxyphenyl)piperidin-1-yl]propyl]-3,4-dihydro-1H-quinolin-2-one oxalate; 6-(3-(4-(2-Methoxyphenyl)-1-piperidinyl)propyl)-3,4-dihydro-2(1H)-quinolinone ethanedioate; 80834-78-2; Oxalic acid - 6-[3-[4-(2-methoxyphenyl)-1-piperidinyl]propyl]-3,4-dihydro-2(1H)-quinolinone (1:1); 6-(3-(4-(2-Methoxyphenyl)piperidin-1-yl)propyl)-3,4-dihydroquinolin-2(1H)-one oxalate
EINECS	Contact for details

Quality Control

Our 2(1H)-Quinolinone, 3,4-Dihydro-6-(3-(4-(2-Methoxyphenyl)-1-Piperidinyl )Propyl)-, Ethanedioate(1:1) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for pharmaceutical research. Certificates of Analysis (COA) detailing all specifications are provided with every shipment to guarantee traceability and batch-to-batch consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider conditions under an inert atmosphere to ensure optimal stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Any single unknown impurity	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.